Company news

Neuropace, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

November 11, 2024

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

November 3, 2024

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

October 21, 2024

NeuroPace Continues to Strengthen Management Team

October 15, 2024

NeuroPace Strengthens Management Team with Two Key Appointments

September 3, 2024

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

August 26, 2024

NeuroPace to Participate in Upcoming Healthcare Conferences in September

August 21, 2024

NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

August 12, 2024

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

July 22, 2024

NeuroPace to Participate in Two Healthcare Conferences in May

May 13, 2024

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 7, 2024

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

April 16, 2024

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

March 26, 2024

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

March 4, 2024

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

February 14, 2024

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

January 7, 2024

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

December 20, 2023

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration

December 3, 2023

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

November 30, 2023

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

November 20, 2023

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

November 5, 2023

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

October 16, 2023

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

October 15, 2023

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

September 19, 2023

NeuroPace to Participate in Upcoming Investor Conferences

August 23, 2023

NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

August 7, 2023

NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market

July 18, 2023

NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023

July 17, 2023

NeuroPace Announces CEO Transition

June 27, 2023

NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales

May 23, 2023

NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

May 3, 2023

NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023

April 16, 2023

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

April 2, 2023

NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results

March 1, 2023

NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

February 9, 2023

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors

January 8, 2023

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

December 20, 2022

NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway

November 29, 2022

NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update

November 7, 2022

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

November 3, 2022

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022

October 24, 2022

NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)

October 10, 2022

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

August 22, 2022

NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update

August 10, 2022

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

August 10, 2022

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

July 20, 2022

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

May 12, 2022

NeuroPace Reports First Quarter 2022 Financial Results

May 11, 2022

NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents

May 3, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 8 decks. Every deck is listed under its year.